OIG's 2012 Agenda Includes Several New Part D, Part B Drug Issues
You may also be interested in...
HHS OIG To Investigate Drug Shortages, Rebates, Other Pharma Issues In 2013
A number of topical issues will be investigated by the HHS Office of Inspector General, according to its work plan for fiscal year 2013. Pharma industry issues are concentrated in the Medicare and Medicaid space.